
Learn how to compare stock performance using price returns, CAGR, risk metrics, and benchmarks. A practical, data-driven guide for smarter equity analysis.
You're staring at two stock charts that look easy to read. One line is higher, the other is lower, and the obvious winner seems clear until dividends, volatility, and the market benchmark change the picture. That's the trap in stock comparison, and it's why the useful question is never just which chart ended higher, but which stock delivered the better result for the amount of risk taken, over the right period, against the right baseline.
| Comparison layer | What it answers | What can mislead you |
|---|---|---|
| Price return | Which stock moved more in the chart | It ignores dividends, splits, and time normalization |
| Total return | Which stock actually compounded better | It still ignores how much volatility was required |
| Risk-adjusted return | Which stock paid you best for the risk taken | It can hide benchmark underperformance |
| Benchmark overlay | Whether the stock beat the market | It can still miss business quality and valuation |
A trader opens two charts, sees one stock above the other, and calls it a win. That conclusion usually holds only if the holding period is short, dividends are irrelevant, and the market barely moved. Once any of those assumptions break, the quick answer starts to fray.
Relative price performance tells part of the story, not the whole thing. Major research tools often place side by side current-session price performance, total-return charts, valuation ratios like P/E, and fundamentals such as EPS, dividend yield, revenue growth, and market capitalization so the comparison can separate a stock's market move from its business quality profile, including up to four tickers on some platforms Moneycontrol's stock comparison view.
That separation matters because a stock can look “better” on price alone while being weaker on the engine underneath it. A cheap-looking name can lag for years if growth stalls. A more expensive one can keep winning if earnings and revenue compound faster.
Modern research screens made this process more standardized by putting side-by-side charts and multi-metric views in one place, including return windows such as 1 month, 6 months, YTD, 1 year, 5 years, and maximum history alongside valuation and financial data Pineify's stock comparison overview. That design highlights the core workflow. The first question is price, the second is total return, the third is business quality, the fourth is risk, and the fifth is whether the stock beat the benchmark.
Practical rule: A stock that “won” on a chart hasn't really won until the comparison includes dividends, time, and the market benchmark.
The cleanest way to compare stock performance is to treat each layer as a filter. Price strips out noise. Total return restores the missing cash flow. Risk metrics show whether the gains were earned smoothly or painfully. Benchmarking tells whether the stock created alpha or just rode the market.

A price chart shows what the market paid for the shares. Total return includes the economic pieces that matter in real ownership, especially dividends and corporate actions like splits. That difference is not cosmetic. Over longer windows, a dividend-paying stock can rank very differently on total return than on price movement alone.
The reason many comparison tools now default to multi-period total-return views is that investors need more than a single endpoint. Historical comparison has become standardized around 1 month, 6 months, YTD, 1 year, 5 years, and max history because different horizons can tell different stories about the same stock Pineify's stock comparison overview. A stock can lead for one year and trail across a full cycle. A second stock can look dull in the short run and compound steadily across several years.
CAGR, or compound annual growth rate, solves the normalization problem. A two-year gain and a seven-year gain cannot be judged fairly from raw percent change alone, because the time base is different. CAGR turns the comparison into a like-for-like annualized rate, which is the cleaner way to compare performance across different holding periods.
That matters when the comparison spans different chart windows. If one stock looks stronger over one year and the other looks stronger over five years, the first question is not which chart is prettier. The question is whether the annualized compounding rate still holds once the entire period is measured consistently.
How Alpha Scala calculates portfolio returns is useful here, because the mechanics of return calculation have to be clear before any comparison can be trusted.
Takeaway: Raw price change is a starting point, not a conclusion. Total return and CAGR are the first serious test of whether a stock compounded better.
A comparison screen can look crowded and still be unhelpful if the wrong metrics get the attention. The useful set is smaller than most traders think. It starts with compounding, then tests how rough that compounding was, then checks whether the stock behaved like the market or differently from it.
| Metric | What it measures | Best used for | Limitation |
|---|---|---|---|
| CAGR | Annualized compounding over time | Comparing unequal holding periods | Can hide path volatility |
| Standard deviation | How spread out returns have been | Measuring return stability | Doesn't show the size of worst losses |
| Maximum drawdown | Peak-to-trough decline | Stress testing downside pain | Doesn't say anything about upside quality |
| Beta | Sensitivity to broad market moves | Understanding market dependence | Doesn't capture absolute return quality |
| Sharpe ratio | Return per unit of total risk | Comparing risk efficiency | Can miss downside asymmetry |
CAGR belongs near the top because it normalizes compounding. Maximum drawdown belongs next because many traders care less about the average path than the worst stretch they would have had to sit through. Beta matters when the comparison includes a benchmark, because a stock that moves like the market is not the same thing as a stock that outperformed the market.
Sharpe ratio is the most useful shorthand when two names posted similar returns but one needed much more volatility to get there. A higher return can still be the weaker trade if it came with a choppier path and worse downside behavior.
A polished comparison terminal is not just a ranking machine. It is a decision filter. If a stock looks great on CAGR but ugly on drawdown, that signals a very different holding experience from one with steady compounding and moderate risk. If beta is high and the benchmark also surged, the stock may have been mostly a market passenger rather than an independent winner.
The right habit is to read the metrics in order. Start with compounding. Check how much risk was required. Then ask whether the result was special or just market exposure.
Two stocks can finish with the same total return and still be very different holdings. One can compound with limited pullbacks. The other can reach the same endpoint only after a path so uneven that the return looks better on a chart than it felt in real time.
That is why expert workflows compare return efficiency using Sharpe, Sortino, Omega, Calmar, and Martin ratios, not just raw performance. PortfoliosLab's stock comparison documentation lays out those measures in a stock-comparison context, and they help separate a smooth compounder from a volatile climber. The same return with less volatility is not a cosmetic improvement. It is a better use of risk capital.
What Sharpe ratio measures in practice is the right reference point when a trader wants a clear view of return per unit of risk. Sharpe is useful because it forces the comparison away from headline gain and toward how efficiently that gain was earned.
No stock should be judged in isolation. Compare each name against a relevant market index such as the S&P 500 or another regional benchmark, because relative performance shows whether the stock generated alpha or moved with the market Investing.com's comparison guide. That benchmark overlay is the difference between “this stock went up” and “this stock beat the market.”
Beta and maximum drawdown connect the comparison back to market and stress regimes. Beta shows sensitivity to broad moves. Drawdown shows how painful the worst stretch was. Together, they stop a trader from overrating a name that only looked strong because the market itself was strong.
Benchmark rule: If a stock outperforms only during market-wide rallies and underperforms when conditions turn, it is not a clean winner. It is a leverage profile with a ticker attached.
A practical check keeps the sequence honest. Test the return. Then test the risk. Then test the benchmark. Without all three, the conclusion is incomplete.
For a disciplined workflow, this is also where the comparison of return quality should stay separate from the charting exercise. A trader can use comparing graph database performance as a reminder that performance comparisons only become useful when the method is clear, the baseline is explicit, and the result can be reproduced.
The workflow starts with a market page, not a headline. A trader picks the relevant stock page, checks the live pricing surface, and then opens the research view where fundamentals and momentum are lined up together. That combination matters because the comparison has to connect what the stock did with what the business delivered.
The first pass should use the stock research view to line up fundamentals, momentum, and an interpretable Alpha Score side by side. A score like that is only useful when it sits next to the underlying numbers that explain it, so the comparison does not become blind faith in a single summary metric. The same view should also make it easy to compare multiple securities, because a proper peer test often needs more than one rival.
A free TradingView indicator is the cleanest way to overlay two or more tickers and watch relative movement in real time. The purpose is not to admire the line work. It is to see whether one stock keeps leading across different segments of the same chart, or whether the edge disappears as soon as the date range changes.
The research view becomes more useful when it's paired with a broader workflow. For traders who also care about tooling architecture and data organization, even a side topic like comparing graph database performance is a reminder that side-by-side evaluation works best when the same variables are aligned consistently.
Saved watchlists and price alerts turn a one-time comparison into an ongoing test. The point is to avoid relying on memory after the first pass. A name that looked expensive against peers can become reasonable after earnings. A stock that looked efficient can weaken if the benchmark keeps rising while its own fundamentals flatten.

The most useful research screens place current-session performance, total-return charts, P/E, EPS, dividend yield, revenue growth, and market cap in one view, and some platforms allow up to four tickers at once Moneycontrol's comparison page. That structure mirrors the workflow traders need.
A useful comparison starts with a simple case. Two peer stocks in the same sector can lead for different reasons, and a broad ETF adds the question that matters most: whether either stock rewarded the extra risk of owning it instead of a diversified basket.
Start with price only, and Stock A may look like the winner because the chart is stronger. Add total return and CAGR, and Stock B can narrow the gap once dividends are included. Add Sharpe and maximum drawdown, and the picture can shift again if Stock A reached its result with less volatility and shallower losses.
That is the point of the layered workflow. The “winner” changes as the lens changes. A stock can lead on raw price movement, trail on total ownership economics, and then move back ahead once return is measured against the path taken to get there. Each layer removes a different kind of illusion.
The cleanest way to run that review is on a platform that lets you compare the names side by side and then break out the result by metric. Alpha Scala's portfolio comparison view is built for that kind of screening, where the same names can be judged first on price behavior, then on the return series behind the chart.
The ETF benchmark is there to answer a different question entirely. It shows whether the stock pair justified the effort of holding an active name instead of a diversified basket. If both stocks failed to beat the ETF on a risk-adjusted basis, the comparison points in a different direction than a price chart would suggest.
Working assumption: A stock selection process should hold up against a broad-market benchmark, not just against a peer chart.
That is why expert workflows compare return efficiency with Sharpe, Sortino, Omega, Calmar, and Martin ratios rather than celebrating one strong number in isolation. The strongest-looking chart is often the least informative one.
The right conclusion from a worked comparison is rarely “buy the stock that went up most.” It is usually “the result depends on whether the goal is raw appreciation, income, risk control, or market outperformance.”
A comparison that looks convincing in a private screen is still only a hypothesis. The cleanest check is a third-party track record with trade history, allocation transparency, and live performance that can be audited after the fact. Publicly tracked portfolios on TipRanks provide that kind of verification layer, which is valuable when a screen produces an answer that feels counterintuitive.
The first thing to inspect is trade history, because a good result means little if the timing is vague. Next comes allocation transparency, since concentration can distort a result and make an apparently smart stock pick look more impressive than it really was. Then comes live performance, which tells whether the disclosed process has held up under real market conditions.
The strongest use case is not ordinary confirmation. It is sanity checking. When a shortlist passes the framework but still feels odd, a public track record helps answer whether the result is plausible or whether the screen is hiding a structural bias.
Public portfolios are not a substitute for primary research. They are a test of consistency. If a comparison says one stock is superior on risk-adjusted terms but a disclosed portfolio built around similar logic keeps stumbling, the model deserves a second look. If the track record and the comparison both point the same way, the result becomes harder to dismiss.
The relevant reference point is the public portfolios page, where disclosed holdings can be checked against the comparison logic instead of treated as a black box.

How much history is enough depends on the holding horizon and the benchmark used. A short window can help for tactical trading, but longer windows are better for judging compounding and regime changes. Traders also often ask whether to use log or arithmetic returns, and the practical answer is to keep the calculation method consistent across every name being compared.
Survivorship bias matters when the peer set changes over time. A stock can look stronger if the comparison group excludes failed rivals. Sortino becomes more useful on top of Sharpe when downside swings matter more than total volatility, which is often the case for traders focused on drawdown control.
The final rule is simple. Treat stock comparison as a workflow, verify the result against a benchmark, and then sanity-check it with live, disclosed track records before acting on it.
Alpha Scala gives traders a place to run that workflow in one screen, from stock research and comparison tools to live portfolios and alert-driven monitoring. If the goal is to compare stock performance with more discipline and less guesswork, visit Alpha Scala and use the research stack to test your next shortlist against fundamentals, risk, and the market benchmark.
Published by AlphaScala under our editorial standards. Educational content only, not personalized financial advice.